Caffeine impairs intramuscular energy balance in patients susceptible to malignant hyperthermia

Muscle and Nerve

Volumn 28, Issue 3, 2003, Pages 353-358

  Textor, Zoran ^a   Beer, Meinrad ^a   Anetseder, Martin ^a   Köstler, Herbert ^a   Kagerbauer, Erwin ^a   Kenn, Werner ^a   Hahn, Dietbert ^a   Roewer, Norbert ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

31P MRS; Caffeine; Diagnosis; Energy metabolism; Malignant hyperthermia

Indexed keywords

CAFFEINE; CALCIUM; INHALATION ANESTHETIC AGENT; PHOSPHATE; PHOSPHORUS 31; SUXAMETHONIUM;

ACIDOSIS; ADULT; ARTICLE; CALCIUM TRANSPORT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG EFFECT; ENERGY BALANCE; FEMALE; HIGH ENERGY PHOSPHATE; HUMAN; HYPERCAPNIA; HYPERKALEMIA; HYPERMETABOLISM; HYPERTHERMIA; MALE; MALIGNANT HYPERTHERMIA; METABOLIC BALANCE; METABOLIC DISORDER; MUSCLE; MUSCLE RIGIDITY; MYOPATHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOLYSIS; SARCOPLASMIC RETICULUM; TACHYCARDIA;

ADULT; AGE FACTORS; CAFFEINE; CALCIUM; CALCIUM SIGNALING; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MALIGNANT HYPERTHERMIA; METABOLIC DISEASES; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; OXIDATIVE PHOSPHORYLATION; PHOSPHOCREATINE; PHOSPHORUS; PHOSPHORUS RADIOISOTOPES; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 0041430543     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10445     Document Type: Article

References (17)

1. Anon. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group. Br J Anaesth 1984;56:1267-1269.
2. Anetseder M, Hager M, Müller CR, Roewer N. Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test. Lancet 2002;359:1579-1580.
3. Anetseder M, Sachs M, Hoyer A, Hartung E, Roewer N. Intramuscular halothane and caffeine application induces local hypermetabolism in MH-susceptible pigs but not in normal pigs. Anesthesiology 2000;93:A1003.
4. Anetseder M, Sachs M, Hoyer A, Hartung E, Roewer N. Local intramuscular application of halothane in MH-susceptible pigs without systemic effects. Anesthesiology 2000;93:A1004.
5. Beer M, Sandstede J, Landschutz W, Viehrig M, Harre K, Horn M, Meininger M, Pabst T, Kenn W, Haase A, von Kienlin M, Neubauer S, Hahn D. Altered energy metabolism after myocardial infarction assessed by P-31-MR-spectroscopy in humans. Eur Radiol 2000;10:1323-1328.
6. 31Phosphorus magnetic resonance spectroscopy characterization of muscular metabolic anomalies in patients with malignant hyperthermia: application to diagnosis. Anesthesiology 1998;88:96-107.
7. Brown TR, Stoyanova R, Greenberg T, Srinivasan R, Murphy-Boesch J. NOE enhancements and T1 relaxation times of phosphorylated metabolites in human calf muscle at 1.5 Tesla. Magn Reson Med 1995;33:417-421.
8. Coronado R, Morrissette J, Sukhareva M, Vaughan DM. Structure and function of ryanodine receptors. Am J Physiol 1994;266:C1485-C1504.
9. Etchrivi TS, Adnet PJ, Tavernier B, Diallo A, Haudecoeur G, Krivosic-Horber RM. Effects of halothane on mechanical response of skeletal muscle from malignant hyperthermia susceptible patients. Arch Physiol Biochem 1998;106:318-324.
10. Graham TE, Spriet LL. Metabolic, catecholamine, and exercise performance responses to various doses of caffeine. J Appl Physiol 1995;78:867-874.
11. Herrmann-Frank A, Lüttgau HC, Stephenson DG. Caffeine and excitation-contraction coupling in skeletal muscle: a stimulating story. J Muscle Res Cell Motil 1999;20:223-237.
12. McComb JM, McMaster EA. Serum myoglobin after cardiac catheterisation. Br Heart J 1982;47:353-356.
13. Monsieurs K, Heytens L, Kloeck C, Martin JJ, Wuyts F, Bossaert L. Slower recovery of muscle phosphocreatine in malignant hyperthermia-susceptible individuals assessed by P-31-MR spectroscopy. J Neurol 1997;244:651-656.
14. Olgin J, Argov Z, Rosenberg H, Tuchler M, Chance B. Non-invasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy. Anesthesiology 1988;68:507-513.
15. Payen JF, Bosson JL, Bourdon L, Jacquot C, Lebas JF, Stieglitz P, Benabid AL. Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vivo with P-31-magnetic resonance spectroscopy. Anesthesiology 1993;78:848-855.
16. Penner R, Neher E, Takeshima H, Nishimura S, Numa S. Functional expression of the calcium release channel from skeletal muscle ryanodine receptor cDNA. FEBS Lett 1989;259:217-221.
17. Tarnopolsky M, Cupido C. Caffeine potentiates low frequency skeletal muscle force in habitual and nonhabitual caffeine consumers. J Appl Physiol 2000;89:1719-1724.